Article
Weight-loss diets modify glucose-dependent insulinotropic polypeptide receptor rs2287019 genotype effects on changes in body weight, fasting glucose, and insulin resistance: the Preventing Overweight Using Novel Dietary Strategies trial.
The American journal of clinical nutrition - 1 Feb 2012
Qi Qibin, Bray George A, Hu Frank B, Sacks Frank M, Qi Lu
Abstract excerpt
BACKGROUND: Glucose-dependent insulinotropic polypeptide [also known as gastric inhibitory polypeptide (GIP)] and its receptor (GIPR) may link overnutrition to obesity, insulin resistance, and type 2 diabetes. A GIPR variant rs2287019 was recently associated with obesity and glucose metabolism. OBJECTIVE: We aimed to examine whether weight-loss diets that vary in fat content may modify the effect of this variant...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
